Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000873:Anthracenes; D000970:Antineoplastic Agents; C031404:bisantrene